Skip to main content
Erschienen in: Clinical & Experimental Metastasis 7/2008

01.11.2008 | Research Paper

Recruitment of dendritic cells in human liver with metastases

verfasst von: M. Gulubova, I. Manolova, G. Cirovski, D. Sivrev

Erschienen in: Clinical & Experimental Metastasis | Ausgabe 7/2008

Einloggen, um Zugang zu erhalten

Abstract

Dendritic cells (DCs) play a key role in the generation of antitumor immune responses as the most potent professional antigen-presenting cells. In this study we examined the distribution of DCs subsets in selected areas of liver metastases and adjacent liver tissue of 74 patients with gastrointestinal cancers (14 gastric, 47 colon, and 13 rectal) using immunohistochemistrty for the DCs markers S-100 protein, HLA-DR, CD1a, and CD83. S-100 protein-positive DCs were localized mainly in clusters in metastases and at the tumor border with the surrounding liver tissue, while HLA-DR-positive DCs were significantly more in number (P < 0.0001) and were diffusely distributed in metastasis stroma and at the tumor border. S-100 protein-positive DCs with mature phenotype were presented around metastases and in the sinusoidal lumena, whereas S-100 protein-positive DCs with less mature phenotype based on their ultrastructure were scattered in the tumor stroma. CD1a- and CD83-positive DCs were observed predominantly in small groups or as single cells in the tumor stroma and in the invasive margin. The numbers of CD1a-positive DCs (immature) and CD83-positive DCs (mature) were comparable, but significantly lower than that of S-100 protein-positive (P < 0.0001) and HLA-DR-positive cells (P < 0.0001).We observed more S-100 protein-positive DCs and HLA-DR-expressing cells in the sinusoids and portal tracts of the liver tissue, surrounding metastases, than in control liver tissue. In conclusion, this study provides additional information on the functional subtypes and distribution of DCs infiltrating metastatic tissue and local liver environment in patients with liver metastases from gastrointestinal cancers.
Literatur
5.
Zurück zum Zitat Suzuki A, Masuda A, Nagata H, Kameoka S, Kikawada Y, Yamakawa M et al (2002) Mature dendritic cells make clusters with T cells in the invasive margin of colorectal carcinoma. The Journal of Pathology 196(1):37–43. doi:10.1002/path.1018 PubMedCrossRef Suzuki A, Masuda A, Nagata H, Kameoka S, Kikawada Y, Yamakawa M et al (2002) Mature dendritic cells make clusters with T cells in the invasive margin of colorectal carcinoma. The Journal of Pathology 196(1):37–43. doi:10.​1002/​path.​1018 PubMedCrossRef
6.
8.
Zurück zum Zitat Yamaguchi K, Saito H, Oro S, Tatebe S, Ikeguchi M, Tsujitani S (2005) Expression of inducible nitric oxide synthase is significantly correlated with expression of vascular endothelial growth factor and dendritic cell infiltration in patients with advanced gastric carcinoma. Oncology 68(4–6):471–478. doi:10.1159/000086990 PubMedCrossRef Yamaguchi K, Saito H, Oro S, Tatebe S, Ikeguchi M, Tsujitani S (2005) Expression of inducible nitric oxide synthase is significantly correlated with expression of vascular endothelial growth factor and dendritic cell infiltration in patients with advanced gastric carcinoma. Oncology 68(4–6):471–478. doi:10.​1159/​000086990 PubMedCrossRef
9.
Zurück zum Zitat Ishigami S, Aikou T, Natsugoe S, Hokita S, Iwashige H, Tokushige M et al (1998) Prognostic value of HLA-DR expression and dendritic cell infiltration in gastric cancer. Oncology 55(1):65–69. doi:10.1159/000011837 PubMedCrossRef Ishigami S, Aikou T, Natsugoe S, Hokita S, Iwashige H, Tokushige M et al (1998) Prognostic value of HLA-DR expression and dendritic cell infiltration in gastric cancer. Oncology 55(1):65–69. doi:10.​1159/​000011837 PubMedCrossRef
10.
Zurück zum Zitat Chen S, Akbar SM, Tanimoto K, Ninomiya T, Iuchi H, Michitaka K et al (2000) Absence of CD83-positive mature and activated dendritic cells at cancer nodules from patients with hepatocellular carcinoma: relevance to hepatocarcinogenesis. Cancer Lett 148(1):49–57. doi:10.1016/S0304-3835(99)00312-2 PubMedCrossRef Chen S, Akbar SM, Tanimoto K, Ninomiya T, Iuchi H, Michitaka K et al (2000) Absence of CD83-positive mature and activated dendritic cells at cancer nodules from patients with hepatocellular carcinoma: relevance to hepatocarcinogenesis. Cancer Lett 148(1):49–57. doi:10.​1016/​S0304-3835(99)00312-2 PubMedCrossRef
13.
Zurück zum Zitat Gulubova M, Vlaykova T (2006) Immunohistochemical assessment of fibronectin and tenascin and their integrin receptors alpha5beta1 and alpha9beta1 in gastric and colorectal cancers with lymph node and liver metastases. Acta Histochem 108(1):25–35. doi:10.1016/j.acthis.2005.12.001 PubMedCrossRef Gulubova M, Vlaykova T (2006) Immunohistochemical assessment of fibronectin and tenascin and their integrin receptors alpha5beta1 and alpha9beta1 in gastric and colorectal cancers with lymph node and liver metastases. Acta Histochem 108(1):25–35. doi:10.​1016/​j.​acthis.​2005.​12.​001 PubMedCrossRef
14.
Zurück zum Zitat Miygawa S, Soeda J, Takagi S, Miwa S, Ichikawa E, Noike T (2004) Prognostic significance of mature dendritic cells and factors associated with their accumulation in metastatic liver tumors from colorectal cancer. Hum Pathol 35(11):1392. doi:10.1016/j.humpath.2004.07.018 CrossRef Miygawa S, Soeda J, Takagi S, Miwa S, Ichikawa E, Noike T (2004) Prognostic significance of mature dendritic cells and factors associated with their accumulation in metastatic liver tumors from colorectal cancer. Hum Pathol 35(11):1392. doi:10.​1016/​j.​humpath.​2004.​07.​018 CrossRef
15.
Zurück zum Zitat Kito A, Tanaka K, Fujimaki H, Nakazawa M, Togo S, Minami M et al (2007) Tumor doubling time and local immune response to hepatic metastases from colorectal cancer. J Surg Oncol 96(6):525–533. doi:10.1002/jso.20806 PubMedCrossRef Kito A, Tanaka K, Fujimaki H, Nakazawa M, Togo S, Minami M et al (2007) Tumor doubling time and local immune response to hepatic metastases from colorectal cancer. J Surg Oncol 96(6):525–533. doi:10.​1002/​jso.​20806 PubMedCrossRef
16.
Zurück zum Zitat Nakajima T, Watanabe S, Sato Y, Shimosato Y, Motoi M, Lennert K (1982) S-100 protein in Langerhans cells, interdigitating reticulum cells and histiocytosis X cells. Gann 73(3):429–432PubMed Nakajima T, Watanabe S, Sato Y, Shimosato Y, Motoi M, Lennert K (1982) S-100 protein in Langerhans cells, interdigitating reticulum cells and histiocytosis X cells. Gann 73(3):429–432PubMed
17.
Zurück zum Zitat Miyazawa Y, Fukuda Y, Imoto M, Koyama Y, Nagura H (1988) Immunohistochemical studies on the distribution of nerve fibers in chronic liver diseases. Am J Gastroenterol 83(10):1108–1114PubMed Miyazawa Y, Fukuda Y, Imoto M, Koyama Y, Nagura H (1988) Immunohistochemical studies on the distribution of nerve fibers in chronic liver diseases. Am J Gastroenterol 83(10):1108–1114PubMed
19.
Zurück zum Zitat Kikuchi K, Kusama K, Taguchi K, Ishikawa F, Okamoto M, Shimada J et al (2002) Dendritic cells in human squamous cell carcinoma of the oral cavity. Anticancer Res 22(2A):545–557PubMed Kikuchi K, Kusama K, Taguchi K, Ishikawa F, Okamoto M, Shimada J et al (2002) Dendritic cells in human squamous cell carcinoma of the oral cavity. Anticancer Res 22(2A):545–557PubMed
20.
Zurück zum Zitat Nagorsen D, Voigt S, Berg E, Stein H, Thiel E, Loddenkemper C (2007) Tumor-infiltrating macrophages and dendritic cells in human colorectal cancer: relation to local regulatory T cells, systemic T-cell response against tumor-associated antigens and survival. J Translat Med 5:62. doi:10.1186/1479-5876-5-62 CrossRef Nagorsen D, Voigt S, Berg E, Stein H, Thiel E, Loddenkemper C (2007) Tumor-infiltrating macrophages and dendritic cells in human colorectal cancer: relation to local regulatory T cells, systemic T-cell response against tumor-associated antigens and survival. J Translat Med 5:62. doi:10.​1186/​1479-5876-5-62 CrossRef
21.
Zurück zum Zitat Sato T, Yamamoto H, Sasaki C, Wake K (1998) Maturation of rat dendritic cells during intrahepatic translocation evaluated using monoclonal antibodies and electron microscopy. Cell Tissue Res 294(3):503–514. doi:10.1007/s004410051201 PubMedCrossRef Sato T, Yamamoto H, Sasaki C, Wake K (1998) Maturation of rat dendritic cells during intrahepatic translocation evaluated using monoclonal antibodies and electron microscopy. Cell Tissue Res 294(3):503–514. doi:10.​1007/​s004410051201 PubMedCrossRef
22.
Zurück zum Zitat Gulubova M (2004) S-100 protein-positive structures in the liver of patients with liver metastases from colorectal cancer. Savr Med 55(6):21–26 Gulubova M (2004) S-100 protein-positive structures in the liver of patients with liver metastases from colorectal cancer. Savr Med 55(6):21–26
23.
Zurück zum Zitat Reis e Sousa C, Austyn JM (1993) Phagocytosis of antigens by Langerhans cells. Adv Exp Med Biol 329:199–204PubMed Reis e Sousa C, Austyn JM (1993) Phagocytosis of antigens by Langerhans cells. Adv Exp Med Biol 329:199–204PubMed
24.
Zurück zum Zitat Matsuno K, Ezaki T, Kudo S, Uehara Y (1996) A life stage of particle-laden rat dendritic cells in vivo: their terminal division, active phagocytosis, and translocation from the liver to the draining lymph. J Exp Med 183(4):1865–1878. doi:10.1084/jem.183.4.1865 PubMedCrossRef Matsuno K, Ezaki T, Kudo S, Uehara Y (1996) A life stage of particle-laden rat dendritic cells in vivo: their terminal division, active phagocytosis, and translocation from the liver to the draining lymph. J Exp Med 183(4):1865–1878. doi:10.​1084/​jem.​183.​4.​1865 PubMedCrossRef
26.
Zurück zum Zitat Abe M, Akbar SM, Horiike N, Onji M (2001) Induction of cytokine production and proliferation of memory lymphocytes by murine liver dendritic cell progenitors: role of these progenitors as immunogenic resident antigen-presenting cells in the liver. J Hepatol 34(1):61–67. doi:10.1016/S0168-8278(00)00004-0 PubMedCrossRef Abe M, Akbar SM, Horiike N, Onji M (2001) Induction of cytokine production and proliferation of memory lymphocytes by murine liver dendritic cell progenitors: role of these progenitors as immunogenic resident antigen-presenting cells in the liver. J Hepatol 34(1):61–67. doi:10.​1016/​S0168-8278(00)00004-0 PubMedCrossRef
29.
Zurück zum Zitat Vinas O, Bataller R, Sancho-Bru P, Gines P, Berenguer C, Enrich C et al (2003) Human hepatic stellate cells show features of antigen-presenting cells and stimulate lymphocyte proliferation. Hepatology Baltimore, Md 38(4):919–929PubMed Vinas O, Bataller R, Sancho-Bru P, Gines P, Berenguer C, Enrich C et al (2003) Human hepatic stellate cells show features of antigen-presenting cells and stimulate lymphocyte proliferation. Hepatology Baltimore, Md 38(4):919–929PubMed
Metadaten
Titel
Recruitment of dendritic cells in human liver with metastases
verfasst von
M. Gulubova
I. Manolova
G. Cirovski
D. Sivrev
Publikationsdatum
01.11.2008
Verlag
Springer Netherlands
Erschienen in
Clinical & Experimental Metastasis / Ausgabe 7/2008
Print ISSN: 0262-0898
Elektronische ISSN: 1573-7276
DOI
https://doi.org/10.1007/s10585-008-9191-1

Weitere Artikel der Ausgabe 7/2008

Clinical & Experimental Metastasis 7/2008 Zur Ausgabe

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.